Chris Bunka

CEO and Chairman,

Lexaria Bioscience Corp.

About Chris

Chris Bunka has been chairman of the board and CEO of Lexaria Bioscience since 2006 and is a serial entrepreneur. He has been involved in several private and public companies since the late 1980's and has extensive experience in the capital markets, corporate governance, project acquisition, and corporate finance. Mr. Bunka is a named inventor on some of Lexaria's pending patents.

Chris's Videos

Lexaria Bioscience Corp.'s proprietary drug delivery technology, DehydraTECHTM, has repeatedly demonstrated, with cannabinoids and nicotine, the ability to increase bio-absorption by up to 5-10x, reduce time of onset from 1-2 hours to just minutes, and mask unwanted tastes since 2016. DehydraTECHTM is being evaluated for orally administered bioactive molecules, including anti-virals, cannabinoids, vitamins, non-steroidal anti-inflammatory drugs (NSAIDs), and nicotine.

Some of Lexaria's 2021 applied research and development milestones include:

  • HYPER-A21-2 - DehydraTECHTM formulations deliver the strongest absorption enhancement results the company has ever recorded, at 2,708% more CBD into bloodstream during the study period than the representative industry standard MCT control formulation.
  • VIRAL-C21-3 - Determined antiviral drugs processed with DehydraTECHTM were effective at inhibiting the COVID-19 SARS-CoV-2 virus.
  • VIRAL-A20-2 - Circulating drug levels in the bloodstream that are twice or even three-times higher with DehydraTECHTM than without.

More cannabis is sold today in edible food format than as a smokable product due to consumer preferences for convenience, discretion, and health. However, old-fashioned cannabis edibles were unpredictable, full of sugar, and often took one to two slow hours to take effect. Newly patented absorption technology from Lexaria Bioscience can be licensed to manufactures around the world to create the best tasting, fast acting and most satisfying edibles the world has ever seen.

Live Now

Accredited Investors Virtual Expo

July 27 - 29, 2021